January 27, 2017
President Naoyuki Mochida Naoyuki Mochida, president of Mochida Pharmaceutical, expressed his resolve on January 25 to quickly expand sales of its ulcerative colitis treatment Lialda (mesalazine), launched in November, and grow it into a flagship. Speaking about the company’s 2017...read more